Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities Jun 17, 2025 08:45AM
Tandem Diabetes Care Announces Upcoming Conference Presentations Feb 8, 2024 04:05PM
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024 Jan 22, 2024 04:05PM
Tandem Diabetes Care’s t:slim X2™ Insulin Pump is the First Automated Insulin Delivery System to Integrate with Abbott’s New FreeStyle Libre® 2 Plus Sensor Jan 8, 2024 08:00AM
Tandem Diabetes (TNDM) Announces Full U.S. Launch of Tandem Source Dec 12, 2023 04:16PM
View Older Stories

Dec 12, 2023 04:15PM Tandem Diabetes Care Announces Full U.S. Launch of Tandem Source, a New Diabetes Management Platform for Customers and Healthcare Providers
Dec 6, 2023 08:30AM Tandem Diabetes Care Launches t:slim X2 Insulin Pump Software with Dexcom G7 CGM Integration in U.S.
Nov 6, 2023 04:05PM Tandem Diabetes Care Announces Upcoming Conference Presentations
Nov 6, 2023 11:50AM TNDM DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action – TNDM
Nov 1, 2023 04:08PM Tandem Diabetes (TNDM) Appoints Mark Novara as EVP and Chief Commercial Officer
Nov 1, 2023 04:06PM Tandem Diabetes Care Appoints Mark Novara as EVP and Chief Commercial Officer
Nov 1, 2023 04:02PM Tandem Diabetes Care Announces Third Quarter 2023 Financial Results
Oct 31, 2023 07:56PM ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action – TNDM
Oct 10, 2023 04:05PM Tandem Diabetes Care to Announce Third Quarter 2023 Financial Results on November 1, 2023
Oct 5, 2023 07:12PM ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TNDM
Sep 23, 2023 08:42AM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TNDM
Aug 24, 2023 04:05PM Tandem Diabetes Care Announces Upcoming Conference Presentations
Aug 3, 2023 04:06PM Tandem Diabetes Care Announces Technology Access Program to Provide Customers with Purchase Pathway to the Tandem Mobi System
Aug 3, 2023 04:02PM Tandem Diabetes Care Announces Second Quarter 2023 Financial Results and Updated Full Year 2023 Financial Guidance
Aug 1, 2023 04:05PM Tandem Diabetes Care to Present at the UBS MedTech, Tools and Genomics Summit 2023
Jul 11, 2023 09:03AM Tandem Diabetes (TNDM) Granted FDA Clearance for Tandem Mobi
Jul 11, 2023 09:00AM Tandem Mobi, World’s Smallest Durable Insulin Delivery System, Receives FDA Clearance
Jul 10, 2023 04:05PM Tandem Diabetes Care to Announce Second Quarter 2023 Financial Results on August 3, 2023
May 24, 2023 04:05PM Tandem Diabetes Care to Present at the Jefferies Healthcare Conference
May 3, 2023 04:05PM Tandem Diabetes Care Announces First Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial Guidance
Apr 20, 2023 04:05PM Tandem Diabetes Care to Present at the BofA Securities 2023 Health Care Conference
Apr 17, 2023 11:02AM Tandem Diabetes (TNDM) Care Announces Control-IQ Technology Meta-analysis Demonstrating Positive Clinical Impact of Automatic Correction Bolusing on Glucose Control in People with Type 1 Diabetes
Apr 17, 2023 11:00AM Tandem Diabetes Care Announces Control-IQ Technology Meta-analysis Demonstrating Positive Clinical Impact of Automatic Correction Bolusing on Glucose Control in People with Type 1 Diabetes
Apr 11, 2023 04:05PM Tandem Diabetes Care to Announce First Quarter 2023 Financial Results on May 3, 2023
Mar 15, 2023 05:05PM Tandem Diabetes Care Announces NEJM Publication of Study Demonstrating Increased Time in Range in Young Children with Type 1 Diabetes Using the t:slim X2 Insulin Pump with Control-IQ Technology
Feb 22, 2023 04:18PM Tandem Diabetes (TNDM) Appoints Rebecca Robertson as Board Chair
Feb 22, 2023 04:15PM Tandem Diabetes Care Appoints New Chair of Board of Directors
Feb 22, 2023 04:05PM Tandem Diabetes Care Announces Fourth Quarter 2022 Financial Results and Full Year 2023 Financial Guidance
Feb 15, 2023 04:05PM Tandem Diabetes Care Announces Upcoming Conference Presentations
Jan 23, 2023 09:00AM Tandem Diabetes Care Completes Acquisition of Insulin Patch Pump Developer, AMF Medical
Jan 19, 2023 04:05PM Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023
Jan 10, 2023 04:05PM Tandem Diabetes Care Reports Preliminary, Unaudited 2022 Sales and Reaffirms 2023 Outlook
Jan 3, 2023 04:05PM Tandem Diabetes Care to Present at the 41st Annual J.P. Morgan Healthcare Conference
Dec 13, 2022 06:43AM Tandem Diabetes (TNDM) to acquire insulin patch pump developer AMF Medical
Dec 13, 2022 06:30AM Tandem Diabetes Care to Acquire Insulin Patch Pump Developer, AMF Medical
Nov 16, 2022 04:05PM Tandem Diabetes Care Earns Great Place to Work Certification™
Nov 10, 2022 05:22PM Tandem Diabetes Care Study Demonstrates Improvements of All Clinical Endpoints in Adults with Type 2 Diabetes Using Control-IQ Technology
Nov 8, 2022 04:05PM Tandem Diabetes Care Announces Upcoming Conference Presentation
Nov 2, 2022 04:05PM Tandem Diabetes Care Announces Third Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance
Oct 27, 2022 04:05PM Tandem Diabetes Care Announces Upcoming Conference Presentations
Oct 4, 2022 04:05PM Tandem Diabetes Care to Announce Third Quarter 2022 Financial Results on November 2, 2022
Sep 14, 2022 09:00AM Parexel Appoints Peyton Howell Chief Operating and Growth Officer; Promotes FDA Veteran Amy McKee, MD, to Chief Medical Officer and Global Head, Oncology Center of Excellence
Sep 14, 2022 09:00AM Parexel Appoints Peyton Howell Chief Operating and Growth Officer; Promotes FDA Veteran Amy McKee, MD, to Chief Medical Officer and Global Head, Oncology Center of Excellence
Aug 22, 2022 04:05PM Tandem Diabetes Care Announces Upcoming Conference Presentations
Aug 18, 2022 08:00AM Tandem Diabetes Care Achieves Milestone of 1 Million Insulin Boluses Delivered Using Its t:connect Mobile App
Aug 3, 2022 04:05PM Tandem Diabetes Care Announces Second Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance
Jul 21, 2022 04:05PM Tandem Diabetes Care Acquires Infusion Set Developer, Capillary Biomedical
Jul 12, 2022 04:05PM Tandem Diabetes Care to Announce Second Quarter 2022 Financial Results on August 3, 2022
Jun 16, 2022 09:17AM Tandem Diabetes (TNDM) Care Welcomes Two New Members to Board of Directors
Jun 16, 2022 09:15AM Tandem Diabetes Care Welcomes Two New Members to Board of Directors
View Older Stories